Pathophysiology of Pre-Eclampsia and Eclampsia: "Bridging Mechanisms to Outcomes" (Tracing the Roots, Understanding the Impact)

Preeclampsia and eclampsia are severe pregnancy complications recognized by hypertension, proteinuria and organ failure. Prompt diagnosis and management reduce the risk of complications of the mother and foetus. Soluble fms- like tyrosine kinase 1, soluble endoglinand angiogenic factors are important biochemical indicators of disease progression. Increased soluble fms-like tyrosine kinase 1 and decreased levels of placental growth factor(PIGF) are related to endothelial injury, which explains the causal association to these events, but markers linked to endothelial dysfunction such as platelet activation and placentation such as pregnancy-associated plasma protein A can be utilized for early diagnosis and follow- up in women with preeclampsia. Excess of uric acid pushes the condition to progress. Methods like doppler ultrasonography helps a lot in assessing uterine artery resistance and predicting the development of Preeclampsia. The condition puts mothers at risk for seizures, stroke, organ failure and heamolysis, elevated liver enzymes, low platelet count(HELLP) syndrome, while kids can face problems like restricted development, early delivery, and low oxygen availability. Patients with preeclampsia receive treatment through blood pressure maintenance along with seizure prevention requiring administration of magnesium sulphate. If hypertension becomes severe medical staff treat it with either labetalol or hydralazine or nifedipine or with magnesium sulphate (for seizures). Severe hypertension may be treated with other medications including labetalol, hydralazine, or nifedipine. Preventive measures through low-dose aspirin and calcium supplements hold hope predominantly for groups at lower disease risks while early detection plus proper monitoring and management lead to successful maternal and foetal outcomes. The significance of developing advanced analytical approaches along with preventive practices stands out as fundamental to minimize difficulties which emerge from high-risk maternal situations.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-21
DOI
https://doi.org/10.5281/zenodo.14899170
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pathophysiology of Pre-Eclampsia and Eclampsia: "Bridging Mechanisms to Outcomes" (Tracing the Roots, Understanding the Impact)

Zenodo (CERN European Organization for Nuclear Research)
Pregnancy and preeclampsia studies
article

Pathophysiology of Pre-Eclampsia and Eclampsia: "Bridging Mechanisms to Outcomes" (Tracing the Roots, Understanding the Impact)

article en

Abstract

Preeclampsia and eclampsia are severe pregnancy complications recognized by hypertension, proteinuria and organ failure. Prompt diagnosis and management reduce the risk of complications of the mother and foetus. Soluble fms- like tyrosine kinase 1, soluble endoglinand angiogenic factors are important biochemical indicators of disease progression. Increased soluble fms-like tyrosine kinase 1 and decreased levels of placental growth factor(PIGF) are related to endothelial injury, which explains the causal association to these events, but markers linked to endothelial dysfunction such as platelet activation and placentation such as pregnancy-associated plasma protein A can be utilized for early diagnosis and follow- up in women with preeclampsia. Excess of uric acid pushes the condition to progress. Methods like doppler ultrasonography helps a lot in assessing uterine artery resistance and predicting the development of Preeclampsia. The condition puts mothers at risk for seizures, stroke, organ failure and heamolysis, elevated liver enzymes, low platelet count(HELLP) syndrome, while kids can face problems like restricted development, early delivery, and low oxygen availability. Patients with preeclampsia receive treatment through blood pressure maintenance along with seizure prevention requiring administration of magnesium sulphate. If hypertension becomes severe medical staff treat it with either labetalol or hydralazine or nifedipine or with magnesium sulphate (for seizures). Severe hypertension may be treated with other medications including labetalol, hydralazine, or nifedipine. Preventive measures through low-dose aspirin and calcium supplements hold hope predominantly for groups at lower disease risks while early detection plus proper monitoring and management lead to successful maternal and foetal outcomes. The significance of developing advanced analytical approaches along with preventive practices stands out as fundamental to minimize difficulties which emerge from high-risk maternal situations.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 41%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pathophysiology of Pre-Eclampsia and Eclampsia: "Bridging Mechanisms to Outcomes" (Tracing the Roots, Understanding the Impact) · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS